A detailed history of Pine Haven Investment Counsel, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Pine Haven Investment Counsel, Inc holds 18,102 shares of ABBV stock, worth $3.08 Million. This represents 2.92% of its overall portfolio holdings.

Number of Shares
18,102
Previous 18,050 0.29%
Holding current value
$3.08 Million
Previous $3.1 Million 15.48%
% of portfolio
2.92%
Previous 2.68%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$163.84 - $199.33 $8,519 - $10,365
52 Added 0.29%
18,102 $3.57 Million
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $309 - $361
2 Added 0.01%
18,050 $3.1 Million
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $9,589 - $10,926
-60 Reduced 0.33%
18,048 $3.29 Million
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $1,376 - $1,549
-10 Reduced 0.06%
18,108 $2.81 Million
Q3 2023

Nov 03, 2023

SELL
$133.59 - $154.65 $56,374 - $65,262
-422 Reduced 2.28%
18,118 $2.7 Million
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $8,348 - $10,388
-63 Reduced 0.34%
18,540 $2.5 Million
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $26,752 - $30,809
-185 Reduced 0.98%
18,603 $2.96 Million
Q4 2022

Jan 17, 2023

BUY
$138.31 - $165.87 $19,363 - $23,221
140 Added 0.75%
18,788 $0
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $7,247 - $8,312
-54 Reduced 0.29%
18,648 $2.5 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $8,257 - $10,497
-60 Reduced 0.32%
18,702 $2.86 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $5,807 - $7,205
-44 Reduced 0.23%
18,762 $3.04 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $2.02 Million - $2.56 Million
18,806 New
18,806 $2.55 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pine Haven Investment Counsel, Inc Portfolio

Follow Pine Haven Investment Counsel, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Haven Investment Counsel, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pine Haven Investment Counsel, Inc with notifications on news.